Vertex Pharmaceuticals Up 30%, Analyst Upgrades to Outperform with $546 Target
Written by Emily J. Thompson, Senior Investment Analyst
Updated: 5d ago
0mins
Source: Benzinga
- Stock Performance: Vertex Pharmaceuticals has seen a 30% increase over the past few months, with analysts expecting this trend to continue, indicating strong market performance and investor confidence.
- Rating Upgrade: RBC Capital analyst Brian Abrahams upgraded Vertex Pharmaceuticals from Sector Perform to Outperform, raising the price target from $455 to $546, reflecting optimism about the company's future growth prospects.
- Dividend Increase: S&P Global raised its dividend from 96 cents to 97 cents per share on January 14, indicating that the company is poised to benefit from a strong debt and capital market cycle, enhancing investor confidence in its financial health.
- Market Reaction: In the latest trading session, Vertex Pharmaceuticals shares rose 1.4% to close at $467.35, demonstrating a positive market response to the analyst rating upgrade, while Kimberly-Clark and S&P Global shares also increased by 2.2% and 1.6%, respectively.
Analyst Views on KMB
Wall Street analysts forecast KMB stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for KMB is 127.71 USD with a low forecast of 95.00 USD and a high forecast of 162.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
14 Analyst Rating
5 Buy
8 Hold
1 Sell
Moderate Buy
Current: 100.640
Low
95.00
Averages
127.71
High
162.00
Current: 100.640
Low
95.00
Averages
127.71
High
162.00
About KMB
Kimberly-Clark Corporation is a global company focused on delivering products and solutions that provide better care. The Company's segments include North America and International Personal Care. The North America segment consists of products encompassing each of its five global daily-need categories across consumer and professional channels including disposable diapers, training and youth pants, swim pants, baby wipes, feminine and incontinence care products, reusable underwear, facial and bathroom tissue, paper towels, napkins, wipers, tissue, towels, soaps and sanitizers and other related products. International Personal Care segment consists of three core categories: Baby & Child Care, Adult Care and Feminine Care, including disposable diapers, training and youth pants, swim pants, baby wipes, feminine and incontinence care products, reusable underwear and other related products. Its portfolio of brands includes Huggies, Kleenex, Scott, Kotex, Cottonelle, Depend, and Pull-Ups.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
